Clinical and hematologic data
| . | T-GLL . | Reactive . |
|---|---|---|
| No. of patients | 36 | 25 |
| Age, mean (range), y | 65 (28-87) | 56 (29-76) |
| Sex: male, female | 20, 16 | 9, 16 |
| Rheumatoid arthritis, no. (%) | 7 (19) | 0 (0) |
| Hemoglobin, mean (range), g/L | 103 (34-145) | 112 (71-158) |
| Hemoglobin, no. (%), less than 120 g/L | 25 (69) | 16 (67) |
| Hemoglobin, no. (%), less than 80 g/L | 7 (19) | 2 (8) |
| ANC, mean (range), × 109/L | 1.92 (0.02-12.08) | 2.62 (0.83-7.72) |
| ANC, no. (%), less than 2 × 109/L | 23 (64) | 13 (54) |
| ANC, no. (%), less than 0.5 × 109/L | 11 (31) | 0 (0) |
| Platelet count, mean (range), × 109/L | 231 (30-634) | 180 (39-508) |
| Platelet count, no. (%), less than 100 × 109/L | 7 (19) | 4 (17) |
| Lymphocyte count, mean (range), × 109/L | 3.26 (0.62-10.77) | 1.44 (0.43-3.74) |
| LGL count, mean (range), × 109/L | 1.99 (0.29-7.12) | 0.58 (0.22-1.65) |
| LGL count, no. (%), more than 2 × 109/L | 15 (42) | 0 (0) |
| . | T-GLL . | Reactive . |
|---|---|---|
| No. of patients | 36 | 25 |
| Age, mean (range), y | 65 (28-87) | 56 (29-76) |
| Sex: male, female | 20, 16 | 9, 16 |
| Rheumatoid arthritis, no. (%) | 7 (19) | 0 (0) |
| Hemoglobin, mean (range), g/L | 103 (34-145) | 112 (71-158) |
| Hemoglobin, no. (%), less than 120 g/L | 25 (69) | 16 (67) |
| Hemoglobin, no. (%), less than 80 g/L | 7 (19) | 2 (8) |
| ANC, mean (range), × 109/L | 1.92 (0.02-12.08) | 2.62 (0.83-7.72) |
| ANC, no. (%), less than 2 × 109/L | 23 (64) | 13 (54) |
| ANC, no. (%), less than 0.5 × 109/L | 11 (31) | 0 (0) |
| Platelet count, mean (range), × 109/L | 231 (30-634) | 180 (39-508) |
| Platelet count, no. (%), less than 100 × 109/L | 7 (19) | 4 (17) |
| Lymphocyte count, mean (range), × 109/L | 3.26 (0.62-10.77) | 1.44 (0.43-3.74) |
| LGL count, mean (range), × 109/L | 1.99 (0.29-7.12) | 0.58 (0.22-1.65) |
| LGL count, no. (%), more than 2 × 109/L | 15 (42) | 0 (0) |
ANC indicates absolute neutrophil count.